A Study to Evaluate the Effects of Veliparib on Heart Rhythms in Patients With Solid Tumors

NCT02009631 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

45

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer
Ovarian Cancer
Colon Cancer
Lung Cancer
Gastric Cancer
Solid Tumors

Interventions

DRUG: Veliparib (ABT-888)
DRUG: Placebo

Sponsor

AbbVie